The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-07-30
DOI
10.3389/fimmu.2020.01680
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunosuppressive Mediators Impair Proinflammatory Innate Lymphoid Cell Function in Human Malignant Melanoma
- (2020) Giuseppe Ercolano et al. Cancer Immunology Research
- Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
- (2020) Andrew M. K. Law et al. Cells
- Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression
- (2020) Junying Chen et al. Frontiers in Oncology
- Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors
- (2020) Ayumi Hashimoto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The innate immune architecture of lung tumors and its implication in disease progression
- (2019) Simon Milette et al. JOURNAL OF PATHOLOGY
- Frequency and Implications of myeloid-derived suppressor cells and lymphocyte subsets in Egyptian patients with hepatitis C virus-related hepatocellular carcinoma
- (2019) Helal F. Hetta et al. JOURNAL OF MEDICAL VIROLOGY
- Purine Release, Metabolism, and Signaling in the Inflammatory Response
- (2019) Joel Linden et al. Annual Review of Immunology
- Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
- (2019) Ivan Perrot et al. Cell Reports
- Immunotherapy for hepatocellular carcinoma: Current and future
- (2019) Michael P Johnston et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immune checkpoint inhibitors for small cell lung cancer: opportunities and challenges
- (2019) Orgilmaa Regzedmaa et al. OncoTargets and Therapy
- Modulation of myeloid derived suppressor cells (MDSCs) functions: a new strategy towards hydrogen sulfide anti‐cancer effects
- (2019) Paola De Cicco et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
- (2019) Beatris Mastelic-Gavillet et al. Journal for ImmunoTherapy of Cancer
- Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
- (2019) Xu Lei et al. CANCER LETTERS
- Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer
- (2018) Yoshikane Yamauchi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Mechanisms of immune evasion in breast cancer
- (2018) Joshua P. Bates et al. BMC CANCER
- RSV ameliorates LLC bearing mice development, decreases G-MDSCs accumulation and impairs its suppressive ability
- (2018) Yilin Zhao et al. CANCER SCIENCE
- Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor–Mediated Natural Killer Cell Function
- (2018) Andrew Stiff et al. CLINICAL CANCER RESEARCH
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer
- (2018) Rong Yang et al. IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
- (2018) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Tumor microenvironment promotes prostate cancer cell dissemination via the Akt/mTOR pathway
- (2018) Junlin Shi et al. Oncotarget
- Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of Helicobacter hepaticus-Induced Colitis
- (2018) Paola De Cicco et al. Frontiers in Immunology
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
- (2018) Viktor Fleming et al. Frontiers in Immunology
- MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression
- (2018) Elisabetta Panza et al. BIOCHEMICAL PHARMACOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- (2018) Arianna Calcinotto et al. NATURE
- Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
- (2018) Peng-Fei Wang et al. OncoImmunology
- The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti–PD-1 Therapy in Patients with Non–Small Cell Lung Cancer
- (2018) Hye Ryun Kim et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- (2018) Christopher Groth et al. BRITISH JOURNAL OF CANCER
- Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2018) Joseph A. Califano et al. CLINICAL CANCER RESEARCH
- Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer
- (2018) Elham Safarzadeh et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
- (2018) Brian J. Christmas et al. Cancer Immunology Research
- Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
- (2018) Kim Ohl et al. Frontiers in Immunology
- Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives
- (2017) Gaël S. Roth et al. EUROPEAN JOURNAL OF CANCER
- Do STAT3 inhibitors have potential in the future for cancer therapy?
- (2017) Andrea L.A. Wong et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- Circulating CD14+ HLA-DR−/low myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery
- (2017) Xing-Hui Gao et al. HEPATOLOGY RESEARCH
- High numbers of myeloid derived suppressor cells in peripheral blood and ascitic fluid of cirrhotic and HCC patients
- (2017) Nadia Elwan et al. IMMUNOLOGICAL INVESTIGATIONS
- Endoplasmic reticulum stress induced LOX-1+ CD15+ polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma
- (2017) Jiang Nan et al. IMMUNOLOGY
- Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
- (2017) Chun-Jung Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Microbiota, Inflammation and Colorectal Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells
- (2017) Yushe Dang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
- (2017) Zoila Lopez-Bujanda et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
- (2017) Richard P. Tobin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
- (2017) Gerardo Botti et al. Journal of Translational Medicine
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Anti-KIT Monoclonal Antibody Treatment Enhances the Antitumor Activity of Immune Checkpoint Inhibitors by Reversing Tumor-Induced Immunosuppression
- (2017) Andrew J. Garton et al. MOLECULAR CANCER THERAPEUTICS
- Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
- (2017) Ben Creelan et al. OncoTargets and Therapy
- Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
- (2017) Ting-Hong Ye et al. Cell Death & Disease
- Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer
- (2017) Kenji Gonda et al. Oncology Letters
- Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
- (2017) David Kung-Chun Chiu et al. Nature Communications
- Neutrophil count is associated with myeloid derived suppressor cell level and presents prognostic value for hepatocellular carcinoma patients
- (2017) Xing Li et al. Oncotarget
- Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells
- (2017) Paul E. Clavijo et al. Oncotarget
- MicroRNAs in melanoma development and resistance to target therapy
- (2017) Luigi Fattore et al. Oncotarget
- Treatment of Advanced Prostate Cancer—A Review of Current Therapies and Future Promise
- (2017) Semini Sumanasuriya et al. Cold Spring Harbor Perspectives in Medicine
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
- (2017) Jieyao Li et al. OncoImmunology
- Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
- (2017) Jessica C. Hassel et al. OncoImmunology
- Myeloid-derived suppressor cells (MDSCs) in metastatic castration-resistant prostate cancer (CRPC) patients (PTS)
- (2016) N. Mehra et al. ANNALS OF ONCOLOGY
- Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study
- (2016) Susanna Mandruzzato et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
- (2016) George A. Dominguez et al. CLINICAL CANCER RESEARCH
- Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
- (2016) Y. Mao et al. CLINICAL CANCER RESEARCH
- Inhibition of curcumin on myeloid-derived suppressor cells is requisite for controlling lung cancer
- (2016) Dan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
- (2016) Cora Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) William J. Gradishar et al. Journal of the National Comprehensive Cancer Network
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D
- (2016) H Bruns et al. LEUKEMIA
- Drug discovery in advanced prostate cancer: translating biology into therapy
- (2016) Timothy A. Yap et al. NATURE REVIEWS DRUG DISCOVERY
- IL-17A produced by peritoneal macrophages promote the accumulation and function of granulocytic myeloid-derived suppressor cells in the development of colitis-associated cancer
- (2016) Yue Zhang et al. TUMOR BIOLOGY
- MicroRNA-15a inhibits the growth and invasiveness of malignant melanoma and directly targets on CDCA4 gene
- (2016) Christopher Alderman et al. TUMOR BIOLOGY
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies
- (2016) Dawei Shou et al. Oncotarget
- Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
- (2016) Elisabetta Panza et al. Oncotarget
- On the origin of myeloid-derived suppressor cells
- (2016) Camilla Rydberg Millrud et al. Oncotarget
- Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
- (2016) Kristine M. Wadosky et al. Oncotarget
- The efficacy and safety of immunotherapy in patients with advanced NSCLC: a systematic review and meta-analysis
- (2016) Liang Zhou et al. Scientific Reports
- Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis
- (2016) Cho-Rong Lee et al. Cell Reports
- Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors
- (2016) Ana P. S. Silva et al. Human Vaccines & Immunotherapeutics
- Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
- (2016) J. Weber et al. Cancer Immunology Research
- Immunotherapy of Colorectal Cancer
- (2016) Dirk Jäger et al. Oncology Research and Treatment
- Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
- (2016) Salman M. Toor et al. Frontiers in Immunology
- Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
- (2016) Rikke B. Holmgaard et al. EBioMedicine
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
- (2015) H.-M. Chen et al. CLINICAL CANCER RESEARCH
- A subpopulation that may correspond to granulocytic myeloid-derived suppressor cells reflects the clinical stage and progression of cutaneous melanoma
- (2015) Ivan Stanojevic et al. INTERNATIONAL IMMUNOLOGY
- Metastatic Colorectal Cancer: Current State and Future Directions
- (2015) Marwan G. Fakih JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptional regulation of myeloid-derived suppressor cells
- (2015) Thomas Condamine et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer
- (2015) Li-Ying OuYang et al. Journal of Translational Medicine
- Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells
- (2015) TAKANOBU MOTOSHIMA et al. ONCOLOGY REPORTS
- Cancer and the microbiota
- (2015) W. S. Garrett SCIENCE
- The immunobiology of myeloid-derived suppressor cells in cancer
- (2015) Morteza Motallebnezhad et al. TUMOR BIOLOGY
- CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
- (2015) Eunyoung Chun et al. Cell Reports
- Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer
- (2015) Pauline L de Goeje et al. OncoImmunology
- Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients
- (2015) Caroline Bergenfelz et al. PLoS One
- RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
- (2015) Brandon L. Probst et al. PLoS One
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Tumor-induced myeloid dysfunction and its implications for cancer immunotherapy
- (2014) Michelle N. Messmer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
- (2014) Manja Idorn et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adverse Immunoregulatory Effects of 5FU and CPT11 Chemotherapy on Myeloid-Derived Suppressor Cells and Colorectal Cancer Outcomes
- (2014) J. Kanterman et al. CANCER RESEARCH
- Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell-Dependent Mechanism
- (2014) S. Chen et al. CANCER RESEARCH
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
- (2014) Thomas Condamine et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
- (2014) M. C. B. Tan et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/ CD40 Therapy
- (2014) J. M. Weiss et al. JOURNAL OF IMMUNOLOGY
- Evidence-based treatment of early-stage melanoma
- (2014) Merrick I. Ross et al. JOURNAL OF SURGICAL ONCOLOGY
- Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells
- (2014) Luke H. Hoeppner et al. Molecular Oncology
- Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
- (2014) Diletta Di Mitri et al. NATURE
- Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer
- (2014) Khaled Ali et al. NATURE
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
- (2014) Ahmad A. Tarhini et al. PLoS One
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)1A.J.A. and R.K. contributed equally to this work.
- (2014) Andrew J. Armstrong et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties
- (2014) Shu-Feng Zhou et al. Drug Design Development and Therapy
- Innate γδT17 cells convert cancer-elicited inflammation into immunosuppression through myeloid-derived suppressor cells
- (2014) Jun Yan et al. OncoImmunology
- Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel
- (2013) Philipp Nuhn et al. BJU INTERNATIONAL
- CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
- (2013) Hiroshi Katoh et al. CANCER CELL
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients
- (2013) Kimberly R. Jordan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
- (2013) Fumitaka Arihara et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Increased CD14+HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients
- (2013) Ang Huang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2013) A. J. Armstrong et al. CLINICAL CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells
- (2013) B. Weide et al. CLINICAL CANCER RESEARCH
- Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice
- (2013) Yunching Chen et al. HEPATOLOGY
- Increased circulating Lin−/lowCD33+HLA-DR−myeloid-derived suppressor cells in hepatocellular carcinoma patients
- (2013) Peng Shen et al. HEPATOLOGY RESEARCH
- Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
- (2013) Moshe Sade-Feldman et al. IMMUNITY
- Myeloid-derived suppressor cells in cancer: recent progress and prospects
- (2013) Yazan S Khaled et al. IMMUNOLOGY AND CELL BIOLOGY
- Circulating immunosuppressive cells of prostate cancer patients before and after radical prostatectomy: Profile comparison
- (2013) Davide Brusa et al. INTERNATIONAL JOURNAL OF UROLOGY
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
- (2013) Tamar Kapanadze et al. JOURNAL OF HEPATOLOGY
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients
- (2013) Marlies E. Heuvers et al. LUNG CANCER
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
- (2013) Bin Zhang et al. PLoS One
- Myeloid-Derived Suppressor Cells Interact with Tumors in Terms of Myelopoiesis, Tumorigenesis and Immunosuppression: Thick as Thieves
- (2013) Alexandra Sevko et al. Journal of Cancer
- CD14+S100A9+Monocytic Myeloid-derived Suppressor Cells and Their Clinical Relevance in Non–Small Cell Lung Cancer
- (2012) Po-Hao Feng et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth
- (2012) Matthew R. Porembka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
- (2012) M. Velasco-Velazquez et al. CANCER RESEARCH
- On the armament and appearances of human myeloid-derived suppressor cells
- (2012) Isabel Poschke et al. CLINICAL IMMUNOLOGY
- Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
- (2012) Kenneth J. Pienta et al. INVESTIGATIONAL NEW DRUGS
- Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells
- (2012) Chun-Te Wu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells
- (2012) Yisheng Zheng et al. MOLECULAR IMMUNOLOGY
- MicroRNA and cancer
- (2012) Martin D. Jansson et al. Molecular Oncology
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
- (2012) Minu K. Srivastava et al. PLoS One
- New insights into chronic inflammation-induced immunosuppression
- (2012) Julia Kanterman et al. SEMINARS IN CANCER BIOLOGY
- Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
- (2012) Taku Fujimura et al. OncoImmunology
- Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction
- (2012) Sabrina Danilin et al. OncoImmunology
- The tumor microenvironment in prostate cancer: elucidating molecular pathways for therapy development
- (2012) Paul G Corn Cancer Management and Research
- A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
- (2011) S. Solito et al. BLOOD
- Improving cancer immunotherapy by targeting tumor-induced immune suppression
- (2011) Trina J. Stewart et al. CANCER AND METASTASIS REVIEWS
- Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
- (2011) Paola Filipazzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
- (2011) B. L. Mundy-Bosse et al. CANCER RESEARCH
- The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment
- (2011) Jung-Mi Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells
- (2011) Jingyan Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
- (2011) Taku Fujimura et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
- (2011) Je-In Youn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
- (2011) Mengde Cao et al. LABORATORY INVESTIGATION
- Characterization of the MDSC Proteome Associated with Metastatic Murine Mammary Tumors Using Label-Free Mass Spectrometry and Shotgun Proteomics
- (2011) Angela M. Boutté et al. PLoS One
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
- (2010) Joris D Veltman et al. BMC CANCER
- IDO inhibits T-cell function through suppressing Vav1 expression and activation
- (2010) Runmei Li et al. CANCER BIOLOGY & THERAPY
- Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity
- (2010) Suzanne Ostrand-Rosenberg CANCER IMMUNOLOGY IMMUNOTHERAPY
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
- (2010) S. Nagaraj et al. CLINICAL CANCER RESEARCH
- Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines
- (2010) Honglin Chen et al. ENDOCRINE-RELATED CANCER
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer
- (2010) John T Isaacs EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma
- (2010) Bhawna Sharma et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
- (2010) M. G. Lechner et al. JOURNAL OF IMMUNOLOGY
- Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
- (2010) Evgeniy Eruslanov et al. JOURNAL OF LEUKOCYTE BIOLOGY
- CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
- (2009) S Singh et al. BRITISH JOURNAL OF CANCER
- Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
- (2009) J. S. Ko et al. CLINICAL CANCER RESEARCH
- Therapeutic targeting of myeloid-derived suppressor cells
- (2009) Stefano Ugel et al. CURRENT OPINION IN PHARMACOLOGY
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
- (2009) Hanh K. Le et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
- (2009) Moses K. Donkor et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14−/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer
- (2009) Chien-Ying Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Recombinant Fusion Protein Encoding a 20-Amino Acid Residue of the Third Extracellular (E3) Domain of CCR2 Neutralizes the Biological Activity of CCL2
- (2009) L. Izhak et al. JOURNAL OF IMMUNOLOGY
- Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
- (2009) Christina L. Roland et al. PLoS One
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Reversal of Myeloid Cell-Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
- (2008) S. Kusmartsev et al. CLINICAL CANCER RESEARCH
- Inflammation and prostate cancer
- (2008) Sonya Vasto et al. Future Oncology
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies
- (2008) Peter Laszlo Lakatos et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now